Skip to main contentSkip to navigation
Sirius Investors

177A.T Stock: Kohjin Bio Co., Ltd. Stock Price, Analysis & Insights

Get live 177A.T stock price $984.00, comprehensive Kohjin Bio Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time 177A.T stock data and investment insights.

984.00
8.29%Today
177A.TKohjin Bio Co., Ltd. • Tokyo Stock Exchange • Healthcare
Market Cap
5.03B
Volume
6.20K
52W High
2020.00
52W Low
961.00

Loading chart data...

Kohjin Bio Co., Ltd. (177A.T) Overview

Kohjin Bio Co., Ltd. (177A.T) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, 177A.T trades at $984.00 with a market capitalization of 5.03B . Over the past 52 weeks, 177A.T has traded between $961.00 and $2020.00 , with the current price positioned at approximately 2% of this range . The stock currently ...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 5.03B
  • Current price: $984.00
  • 52-week range: $961.00 - $2020.00
  • P/E ratio: 20.04

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biological materi...

Company Information

CEO
Takahito Nakamura
Sector
Healthcare
Industry
Biotechnology
Employees
159

Contact Information

Address
5-1-3
Country
JP

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 20.0)

Lower volatility stock (Beta: -0.04) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Kohjin Bio Co., Ltd. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Kohjin Bio Co., Ltd.
  • Investors should consider how Kohjin Bio Co., Ltd. fits within their overall portfolio allocation

Market Cap

5.03B

P/E Ratio (TTM)

20.04

Beta

-0.04

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

43/100 ⭐⭐⭐

Overall
-1.0%
NYSE
-1.6%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+0.3%+1.3%+1.9%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.